Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement

BACKGROUND: Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status. Current evidence suggests that the incidence of GO in Europe may be declining, however data on the prevalence of this disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Perros, P., Hegedüs, L., Bartalena, L., Marcocci, C., Kahaly, G. J., Baldeschi, L., Salvi, M., Lazarus, J. H., Eckstein, A., Pitz, S., Boboridis, K., Anagnostis, P., Ayvaz, G., Boschi, A., Brix, T. H., Currò, N., Konuk, O., Marinò, M., Mitchell, A. L., Stankovic, B., Törüner, F. B., von Arx, G., Zarković, M., Wiersinga, W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397790/
https://www.ncbi.nlm.nih.gov/pubmed/28427469
http://dx.doi.org/10.1186/s13023-017-0625-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397790/
https://www.ncbi.nlm.nih.gov/pubmed/28427469
http://dx.doi.org/10.1186/s13023-017-0625-1

Ejemplares similares